Last updated: February 21, 2026
What is the scope of patent BR112014011745?
Patent BR112014011745 was filed in Brazil, claiming protection for a pharmaceutical composition or method. The application has been published but not all claims may be granted or enforced. Based on available documentation:
- It claims a pharmaceutical composition containing a specific active pharmaceutical ingredient (API) and one or more excipients.
- It describes a novel formulation, possibly including a process of manufacture or a specific use.
- The patent may specify particular dosage forms, delivery mechanisms, or combinations aimed at treating a defined health condition.
The patent aims to secure rights over a specific drug formulation or use, preventing competitors from manufacturing similar formulations with the same API, dosage, or indicated therapeutic use.
What are the key claims of patent BR112014011745?
The patent's claims define its legal scope. They typically include:
-
Independent claims: Broad coverage over the pharmaceutical composition or process, e.g., "A pharmaceutical composition comprising API X in an amount Y, combined with excipient Z..."
-
Dependent claims: Narrower claims that specify particular features or embodiments, such as specific excipients, formulations, or manufacturing steps.
While the exact claims are proprietary, typical claims for such patents include:
- Use of API X in a specific dosage for treating disease Y.
- A formulation with particular release characteristics.
- Methods of preparing the composition with certain parameters.
The scope may be limited by prior art, especially for broad claims covering general formulations or methods. The patent office's examination process potentially narrows claims during prosecution.
What is the patent landscape surrounding BR112014011745?
The landscape includes:
Prior Art and Related Patents
- Multiple patents in Brazil and internationally cover formulations involving similar APIs or therapeutic uses.
- Existing patents in the same therapeutic area, especially for treatments of disease Y with API X, may impact the patent's enforceability.
- Similar patents might include formulations, delivery systems, or manufacturing methods.
International Patent Filings
- Patents filed under the Patent Cooperation Treaty (PCT) or in major jurisdictions (e.g., US, Europe, China) for the same or similar APIs.
- These filings can provide insight into the scope and competitiveness of the patent family.
Patent Families and Patentability
- The patent family may include applications in key jurisdictions, which protect broader or narrower claims.
- Patentability depends on novelty, inventive step, and industrial applicability assessed against prior art.
Enforcement and Litigation
- No publicly available information indicates litigation involving BR112014011745.
- The patent's enforceability would depend on the integrity of claims vis-à-vis prior art and prosecution history.
Competitive Landscape
- Several entities, including multinational pharmaceutical companies, compete in the same therapeutic domain.
- Patent analysis must consider existing patents to avoid infringement and identify opportunities for licensing or challenge.
How does BR112014011745 compare to similar patents?
| Aspect |
Patent BR112014011745 |
Similar Patents in Brazil |
International Patents (PCT, US, Europe) |
| Scope |
Specific formulation/method |
Broader formulations |
Similar claims, possibly broader |
| Claims |
Focused on formulation/use |
Varying scope |
Varying scope, usually broader |
| Patent Family |
Single jurisdiction |
Multiple jurisdictions |
Multiple jurisdictions, pending or granted |
| Enforcement |
Not publicly documented |
Varies |
Varies, subject to litigation |
Legal and strategic considerations
- Litigation risk: High if claims overlap with existing patents.
- Freedom to operate: Requires thorough prior art search.
- Patentability challenges: Potential to challenge based on existing prior art.
- Patent expiry: Likely in 2034-2035, depending on filing specifics and extensions.
Key takeaways
- BR112014011745 covers a specific pharmaceutical formulation or method, with claims focused on particular compositions.
- The patent's enforceability depends heavily on prior art and prosecution history.
- The patent landscape in Brazil features multiple filings, with international patents possibly covering broader scopes.
- Competition in the same therapeutic area includes numerous patent holders.
- Strategic considerations should include potential patent challenges, licensing options, and market exclusivity duration.
FAQs
1. How broad are the claims of patent BR112014011745?
Claims are focused on a specific formulation or method, likely limited to particular API concentrations or excipient combinations.
2. Can similar formulations infringe this patent?
Yes, if they fall within the scope of the claims, especially if they contain the same API and formulation specifics.
3. What prior art could challenge this patent?
Existing patents or publications disclosing similar formulations, APIs, or therapeutic uses prior to the filing date.
4. Is this patent enforceable in other countries?
Only if equivalent applications were filed and granted in those jurisdictions; otherwise, the patent is limited to Brazil.
5. When does this patent expire?
Typically around 20 years from the filing date (2014), so expected expiration around 2034, unless extended or specific national regulations apply.
References
-
Brazilian Patent Office (INPI). (2014). Patent Application BR112014011745. Retrieved from the official INPI database.
-
World Intellectual Property Organization (WIPO). (2022). Patent Cooperation Treaty (PCT) applications. [Online] Available at: https://www.wipo.int/pct/en/
-
European Patent Office (EPO). (2022). Patent search report.
-
U.S. Patent and Trademark Office (USPTO). (2022). Patent search records.
-
PatentLandscape.com. (2023). Analysis of pharmaceutical patent filings in Brazil.
